Back to search

Sweden· SE-20070508000080

Vimpat 150 mg Filmdragerad tablett

A medicinal product containing lacosamide, registered in Sweden by UCB Pharma S.A..

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedVimpat 150 mg Filmdragerad tablettATC—REGISTER NO.SE-20070508000080PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Lacosamide
Manufacturer
UCB Pharma S.A.
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20070508000080

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lacosamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lacosamide products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Lacopat, Lacopat Packung Zur Behandlungseinleitung
  • Belgium · Lacosamid Hikma, Lacosamide Eg
  • Bulgaria · Канилад, Лакозамид Гриндекс
  • Cyprus · Kanilad, Lacosadel
  • Czechia · Arkvimma, Kanilad
  • Germany · Kanilad, Lackepila
  • Denmark · 200 mg, Lacosamid Opko Health Spain
  • Estonia · Kanilad, Lacosamide Alembic
  • Spain · Balmid, Kanilad
  • Finland · Lacosamide Fresenius Kabi, Lacosamide Grindeks
  • France · Lacosamide Arrow, Lacosamide Biogaran
  • United Kingdom (Northern Ireland) · Lacosamide, Lacosamide Amarox
  • Greece · Anlamyl, Josamec
  • Croatia · Kanilad, Lacosamide Grindeks
  • Hungary · Anlamyl, Arkvimma
  • Ireland · Lacosamide Ascend, Lacosamide Fresenius Kabi
  • Iceland · Josamec, Lacosamide Accord
  • Italy · Lacosamide Aurobindo, Lacosamide Doc
  • Liechtenstein · Lacosamid Fresenius Kabi, Lacosamide Accord
  • Lithuania · Lacosamide Fresenius Kabi, Lacosamide Grindeks
  • Luxembourg · Lacosamide Eg
  • Latvia · Kanilad, Lacosamide Fresenius Kabi
  • Malta · Anlamyl, Kanilad
  • Netherlands · Cosim, Lacosamide Amarox
  • Norway · Lacosamide Accord, Lacosamide Fresenius Kabi
  • Poland · Arkvimma, Epilantin
  • Portugal · Lacosamida Alter, Lacosamida Aristo
  • Romania · Lacosamidă Teva
  • Slovenia · Lacosabil, Lacosamide Grindeks
  • Slovakia · Arkvimma, Kanilad

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ef488e4c-9551-4e14-8b90-49262e170e0c
GET /v1/drugs/ef488e4c-9551-4e14-8b90-49262e170e0c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EMA",
    "EPAR"
  ],
  "se_npl_id": "20070508000080",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20070508000080",
  "product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/vimpat"
}

See everything about lacosamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.